BE689902A - - Google Patents

Info

Publication number
BE689902A
BE689902A BE689902DA BE689902A BE 689902 A BE689902 A BE 689902A BE 689902D A BE689902D A BE 689902DA BE 689902 A BE689902 A BE 689902A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE689902A publication Critical patent/BE689902A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16Compounds containing any of the groups, e.g. aminoguanidine
    • C07C281/18Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/96Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having three double bonds between ring members or between ring members and non-ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE689902D 1965-11-19 1966-11-18 BE689902A (en:Method)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1598865A CH474486A (de) 1965-11-19 1965-11-19 Verfahren zur Herstellung neuer Diphenylharnstoffe
CH1409266 1966-09-29

Publications (1)

Publication Number Publication Date
BE689902A true BE689902A (en:Method) 1967-05-18

Family

ID=25713607

Family Applications (1)

Application Number Title Priority Date Filing Date
BE689902D BE689902A (en:Method) 1965-11-19 1966-11-18

Country Status (11)

Country Link
US (2) US3560566A (en:Method)
AT (1) AT269166B (en:Method)
BE (1) BE689902A (en:Method)
BR (1) BR6684680D0 (en:Method)
CH (1) CH474486A (en:Method)
DE (1) DE1568349A1 (en:Method)
DK (1) DK118457B (en:Method)
FR (3) FR1504097A (en:Method)
GB (1) GB1142066A (en:Method)
NL (1) NL6616277A (en:Method)
SE (1) SE323360B (en:Method)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1311432A (en) * 1971-01-07 1973-03-28 Ici Ltd Guanidine derivatives their preparation and antiviral compositions containing them
DE3360148D1 (en) * 1982-02-10 1985-06-05 Beecham Group Plc Guanidine derivatives
US5238941A (en) * 1988-03-25 1993-08-24 Ciba-Geigy Corporation Arylhydrazones and pharmaceutical compositions thereof
US4971986A (en) * 1988-03-25 1990-11-20 Ciba-Geigy Corporation Arylhydrazones useful as SAMDC inhibitors
US5599984A (en) * 1994-01-21 1997-02-04 The Picower Institute For Medical Research Guanylhydrazones and their use to treat inflammatory conditions
US6008255A (en) * 1994-01-21 1999-12-28 The Picower Institute For Medical Research Guanylhydrazones and their use to treat inflammatory conditions
WO2002000613A2 (en) * 2000-06-27 2002-01-03 Axxima Pharmaceuticals Ag Inhibitors of hepatitis b virus infection
US20050282909A1 (en) * 2003-11-14 2005-12-22 Diks Sander H Guanylhydrazones in methods of treatment or diagnosis as modulators of signal transduction
PL1778265T3 (pl) * 2004-08-17 2013-10-31 Ferring Bv Związki guanylohydrazonowe, kompozycje, sposoby wytwarzania i stosowania
US8912214B2 (en) * 2005-07-29 2014-12-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Use of Chk2 kinase inhibitors for cancer treatment
CA2690410C (en) * 2007-06-12 2015-09-29 Provid Pharmaceuticals, Inc. Kinase inhibitors, compositions thereof, and methods of use therewith
WO2014193969A2 (en) * 2013-05-28 2014-12-04 The Regents Of The University Of California Compounds for the treatment of hypertension and hypertensive end stage renal disease

Also Published As

Publication number Publication date
US3560557A (en) 1971-02-02
US3560566A (en) 1971-02-02
FR6139M (en:Method) 1968-06-24
FR1504097A (fr) 1967-12-01
DE1568349A1 (de) 1970-02-12
NL6616277A (en:Method) 1967-05-22
DK118457B (da) 1970-08-24
CH474486A (de) 1969-06-30
BR6684680D0 (pt) 1973-12-18
FR6153M (en:Method) 1968-07-01
AT269166B (de) 1969-03-10
GB1142066A (en) 1969-02-05
SE323360B (en:Method) 1970-05-04

Similar Documents

Publication Publication Date Title
FR6153M (en:Method)
JPS434034Y1 (en:Method)
JPS4317955Y1 (en:Method)
JPS4110024Y1 (en:Method)
JPS4222092Y1 (en:Method)
JPS4314811B1 (en:Method)
JPS4221983Y1 (en:Method)
JPS4318258Y1 (en:Method)
JPS4314273Y1 (en:Method)
BE675463A (en:Method)
BE675296A (en:Method)
BE597362A (en:Method)
NL6615690A (en:Method)
BE675062A (en:Method)
BE689402A (en:Method)
BE689295A (en:Method)
BE681553A (en:Method)
BE675757A (en:Method)
BE675718A (en:Method)
BE675713A (en:Method)
BE675703A (en:Method)
BE675679A (en:Method)
BE675656A (en:Method)
BE674982A (en:Method)
BE675451A (en:Method)